Department of Psychiatry, School of Medicine, Yale University, New Haven, CT, USA; VA New England Mental Illness, Research, Education and Clinical Center (MIRECC), VA Connecticut Healthcare System, West Haven, CT, USA; Department of Public Health Sciences, School of Medicine, University of Connecticut, Farmington, CT, USA.
Mood Disorder Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, ON, Canada.
J Affect Disord. 2023 Jan 15;321:33-40. doi: 10.1016/j.jad.2022.10.025. Epub 2022 Oct 20.
The associations of current and remitted bipolar disorder (BD) with health-related quality of life (HRQOL) have been under-studied, and we aim to address these gaps.
The 2012-2013 National Epidemiological Survey on Alcohol and Related Conditions III (NESARC III) surveyed a nationally representative sample of non-institutionalized adults in the US. Using DSM-5 criteria, three groups were operationalized as: 1) adults who met criteria for BD in the past year (i.e., current BD; n = 566 unweighted); and 2) adults who met criteria for BD previously but not in the past year (i.e., BD in remission; n = 187); and 3) adults with no BD in their lifetime (n = 35,556). HRQOL and quality-adjusted life years (QALYs) were compared by these groups. Multivariable-adjusted regression analyses were used to adjust for and examine the role of covariates.
Overall, 1.5 % of the study sample, representing 3.6 million adults nationwide, met criteria for current BD, and 0.5 %, representing 1.3 million adults, met criteria for BD in remission. Adults with current BD and BD in remission had lower mental HRQOL and QALYs, as compared to adults who never had BD. However, these differences were no longer significant when adjusted for behavioral co-morbidities (e.g., psychiatric and substance use disorders).
Both current BD and BD in remission were adversely associated with HRQOL and QALYs, while these associations were not independent of behavioral co-morbidities. Because behavioral co-morbidities are common in individuals with current BD or those with BD in remission, they should be treated together to improve HRQOL.
目前和缓解的双相情感障碍(BD)与健康相关生活质量(HRQOL)之间的关联尚未得到充分研究,我们旨在解决这些差距。
2012-2013 年全国酒精和相关情况流行病学调查 III(NESARC III)调查了美国非机构化成年人的全国代表性样本。使用 DSM-5 标准,将三组定义为:1)过去一年符合 BD 标准的成年人(即当前 BD;未加权 n=566);2)以前符合 BD 标准但过去一年未符合的成年人(即 BD 缓解;n=187);3)一生中没有 BD 的成年人(n=35,556)。通过这些群体比较 HRQOL 和质量调整生命年(QALYs)。使用多变量调整回归分析调整协变量并检查其作用。
总体而言,研究样本的 1.5%,代表全国 360 万成年人,符合当前 BD 的标准,0.5%,代表 130 万成年人,符合缓解 BD 的标准。与从未患有 BD 的成年人相比,患有当前 BD 和缓解 BD 的成年人的心理健康 HRQOL 和 QALYs 较低。然而,当调整行为合并症(例如,精神和物质使用障碍)时,这些差异不再显著。
当前的 BD 和缓解的 BD 都与 HRQOL 和 QALYs 呈不利关联,而这些关联与行为合并症无关。由于当前 BD 或缓解 BD 的个体中常见行为合并症,应将其一起治疗以改善 HRQOL。